Actinium Pharmaceuticals
ATNM
ATNM
28 hedge funds and large institutions have $6.39M invested in Actinium Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 11 increasing their positions, 1 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $18K
Holders
28
Holding in Top 10
–
Calls
–
Puts
$18K
Top Buyers
| 1 | +$228K | |
| 2 | +$108K | |
| 3 | +$72.2K | |
| 4 |
AC
Armistice Capital
New York
|
+$54.4K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$40K |
Top Sellers
| 1 | -$1.4M | |
| 2 | -$915K | |
| 3 | -$589K | |
| 4 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$192K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$34K |